Bath & Body Works (NYSE:BBWI) Given New $34.00 Price Target at Barclays

Bath & Body Works (NYSE:BBWI) had its target price boosted by Barclays from $28.00 to $34.00 in a research note published on Tuesday morning,Benzinga reports. They currently have an underweight rating on the stock.

Several other equities analysts also recently commented on the company. JPMorgan Chase & Co. lowered their price objective on Bath & Body Works from $42.00 to $39.00 and set a “neutral” rating on the stock in a research report on Thursday, August 29th. Robert W. Baird lowered their price target on Bath & Body Works from $54.00 to $45.00 and set an “outperform” rating on the stock in a report on Thursday, August 29th. Bank of America cut their price objective on shares of Bath & Body Works from $54.00 to $45.00 and set a “buy” rating for the company in a report on Thursday, August 29th. Wells Fargo & Company dropped their target price on shares of Bath & Body Works from $35.00 to $32.00 and set an “equal weight” rating for the company in a research report on Wednesday, November 6th. Finally, Deutsche Bank Aktiengesellschaft cut their target price on shares of Bath & Body Works from $57.00 to $54.00 and set a “buy” rating for the company in a research note on Monday, August 26th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and nine have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $41.88.

Bath & Body Works Trading Up 1.9 %

NYSE BBWI opened at $35.90 on Tuesday. Bath & Body Works has a 12 month low of $26.20 and a 12 month high of $52.99. The stock has a market cap of $7.87 billion, a price-to-earnings ratio of 8.76, a PEG ratio of 1.14 and a beta of 1.79. The company’s 50 day moving average is $30.93 and its two-hundred day moving average is $35.65.

Bath & Body Works (NYSE:BBWI) last announced its quarterly earnings data on Wednesday, August 28th. The company reported $0.37 EPS for the quarter, beating the consensus estimate of $0.35 by $0.02. The firm had revenue of $1.53 billion for the quarter, compared to the consensus estimate of $1.54 billion. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. Sell-side analysts forecast that Bath & Body Works will post 3.18 EPS for the current year.

Bath & Body Works Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 6th. Stockholders of record on Friday, November 22nd will be paid a $0.20 dividend. This represents a $0.80 annualized dividend and a dividend yield of 2.23%. The ex-dividend date is Friday, November 22nd. Bath & Body Works’s payout ratio is 19.51%.

Insider Transactions at Bath & Body Works

In related news, CEO Gina Boswell purchased 6,000 shares of the firm’s stock in a transaction that occurred on Wednesday, October 9th. The shares were bought at an average price of $29.64 per share, for a total transaction of $177,840.00. Following the acquisition, the chief executive officer now owns 242,987 shares of the company’s stock, valued at approximately $7,202,134.68. This represents a 2.53 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Company insiders own 0.27% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the company. First Community Trust NA bought a new stake in shares of Bath & Body Works in the 2nd quarter worth about $30,000. True Wealth Design LLC raised its position in Bath & Body Works by 5,270.0% in the 3rd quarter. True Wealth Design LLC now owns 1,074 shares of the company’s stock worth $34,000 after purchasing an additional 1,054 shares during the period. Livforsakringsbolaget Skandia Omsesidigt lifted its stake in Bath & Body Works by 300.0% in the third quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,200 shares of the company’s stock worth $38,000 after purchasing an additional 900 shares during the last quarter. Wilmington Savings Fund Society FSB bought a new stake in Bath & Body Works in the third quarter worth about $39,000. Finally, TD Private Client Wealth LLC boosted its position in shares of Bath & Body Works by 24.2% during the third quarter. TD Private Client Wealth LLC now owns 1,697 shares of the company’s stock valued at $54,000 after buying an additional 331 shares during the period. Institutional investors own 95.14% of the company’s stock.

Bath & Body Works Company Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.